© 2024
NPR News, Colorado Stories
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Vioxx Sparks Debate over Malpractice Reform

By Julie Rovner
Published November 21, 2004 at 10:00 PM MST

Following the recent removal of the drug Vioxx from the market, lawmakers are reconsidering a portion of medical malpractice reform. Caps in the malpractice bill would affect pharmaceutical and medical product manufacturers. Democrats oppose the caps, but Sen. Orrin Hatch (R-UT) calls the situation a "feeding frenzy" for trial lawyers. NPR's Julie Rovner reports.

Copyright 2004 NPR
NPR News
Julie Rovner
Julie Rovner is a health policy correspondent for NPR specializing in the politics of health care.Reporting on all aspects of health policy and politics, Rovner covers the White House, Capitol Hill, the Department of Health and Human Services in addition to issues around the country. She served as NPR's lead correspondent covering the passage and implementation of the 2010 health overhaul bill, the Patient Protection and Affordable Care Act.
See stories by Julie Rovner